Cutaneous temperature measurements in men with penile prostheses: a comparison study.
To evaluate and compare the cutaneous temperature of the penis in normal men, those with erectile dysfunction (ED), those with semirigid penile prostheses (SRPPs), and those with inflatable penile prostheses (IPPs), and those before and after trimix injection to create a penile erection. A total of 68 patients were evaluated. Five patient groups were identified, including men with normal erectile function, with ED, with SRPPs, with IPPs, and following intracavernosal injection of trimix solution. Cutaneous glans temperature increased significantly by more than 2.2 degrees C in the trimix-injected group compared with all other groups (P<0.001). Using cutaneous temperature measurements of the penis, patients with SRPPs had significantly lower cutaneous glans temperatures than normals (P<0.02), those in the ED group (P<0.04), and those in the IPP-deflated group (P<0.01). The mean temperature difference was 1.44+/-0.40 degrees C. Using cutaneous temperature measurements of the penis, men with SRPPs have a colder glans as compared with men with normal erectile function, ED, IPPs, and those who have received an injection of trimix. Men with normal erectile function, ED, and IPPs did not have significant cutaneous temperature differences.
Fogarty
J D
JD
Urology, Montefiore MC/Albert Einstein COM, Bronx, NY 10467, USA. jamesdfogarty@yahoo.com
Bleustein
C B
CB
Hafron
J M
JM
Melman
A
A
D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000527:Alprostadil / Q000008:administration & dosage; D007172:Erectile Dysfunction / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D007267:Injections; D008297:Male; D008875:Middle Aged; D010208:Papaverine / Q000008:administration & dosage; D010410:Penile Erection; D015917:Penile Prosthesis; D010413:Penis / Q000187:drug effects; D010646:Phentolamine / Q000008:administration & dosage; D010726:Phosphodiesterase Inhibitors / Q000008:administration & dosage; D012881:Skin Temperature; D012996:Solutions
D000317:Adrenergic alpha-Antagonists; D010726:Phosphodiesterase Inhibitors; D012996:Solutions; D010208:Papaverine; D000527:Alprostadil; D010646:Phentolamine